Jemperli Den europeiske union - norsk - EMA (European Medicines Agency)

jemperli

glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.

Cleye 0.12 mg/ ml Norge - norsk - Statens legemiddelverk

cleye 0.12 mg/ ml

elara pharmaservices europe ltd - nafazolinhydroklorid - Øyedråper, oppløsning - 0.12 mg/ ml

Kloramfenikol Santen 10 mg/ g Norge - norsk - Statens legemiddelverk

kloramfenikol santen 10 mg/ g

santen oy - kloramfenikol - Øyesalve - 10 mg/ g

Simplex 200 mg/ g / 800 mg/ g Norge - norsk - Statens legemiddelverk

simplex 200 mg/ g / 800 mg/ g

teva b.v. - parafin, flytende / vaselin, gul - Øyesalve - 200 mg/ g / 800 mg/ g

Cosopt sine 20 mg/ ml / 5 mg/ ml Norge - norsk - Statens legemiddelverk

cosopt sine 20 mg/ ml / 5 mg/ ml

santen oy - dorzolamidhydroklorid / timololmaleat - Øyedråper, oppløsning - 20 mg/ ml / 5 mg/ ml

Taflotan sine 15 mikrog/ ml Norge - norsk - Statens legemiddelverk

taflotan sine 15 mikrog/ ml

santen oy - tafluprost - Øyedråper, oppløsning - 15 mikrog/ ml